A SARS-CoV-2 surrogate virus neutralization test based on antibody-mediated blockage of ACE2–spike protein–protein interaction

Journal: Nature Biotechnology

Published: 2020-07-23

DOI: 10.1038/s41587-020-0631-z

Affiliations: 14

Authors: 16

Go to article
Institutions Share
Duke-NUS Medical School, Singapore 0.47
Genscript Biotech Corporation, China 0.13
Second Hospital of Nanjing, NJUCM, China 0.09
National University of Singapore (NUS), Singapore 0.06
SingHealth Duke-NUS Global Health Institute (SDGHI), Singapore 0.06
National Centre for Infectious Diseases (NCID), Singapore 0.06
Nanjing Medical University (NJMU), China 0.03
Tan Tock Seng Hospital (TTSH), Singapore 0.03
Lee Kong Chian School of Medicine, Singapore 0.03
National University Health System (NUHS), Singapore 0.02
Institute of Molecular and Cell Biology (IMCB), A*STAR, Singapore 0.02

Return

Except where otherwise noted © 2021 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER